SCHEMBL7738734

SCHEMBL7738734

CCCCNC(=O)c1c[nH]c2ccc(N3CCOCC3)cc2c1=O

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.72
KDM4E B2RXH2 7/20 0.72
MAPT P10636 6/20 0.56
HPGD P15428 6/20 0.56
TDP1 Q9NUW8 1/20 0.56
KMT2A Q03164 2/20 0.56
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
GAA P10253 2/20 0.52
USP2 O75604 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HSD17B10 Q99714 1/20 0.52
POLB P06746 1/20 0.51
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6205521 0.80 ALDH1A1 (0.67) ALDH1A1KDM4EMAPTHPGDKMT2A
SCHEMBL27774057 0.80 KDM4E (0.60) ALDH1A1KDM4EMAPTHPGDTDP1
SCHEMBL7740284 0.79 JAK2 (0.49) ALDH1A1KDM4EMAPTHPGDKMT2A
SCHEMBL27795083 0.78 PYGL (0.62) ALDH1A1KDM4EMAPTHPGDTDP1
SCHEMBL27795086 0.78 KDM4E (0.60) ALDH1A1KDM4EMAPTHPGDTDP1
SCHEMBL19073035 0.76 ALDH1A1 (0.73) ALDH1A1KDM4EMAPTHPGDKMT2A
SCHEMBL27743061 0.76 FGFR1 (0.46) ALDH1A1KDM4EMAPTHPGDTDP1
SCHEMBL3810147 0.74 TRPV1 (0.66) KDM4EPOLB
SCHEMBL3813966 0.74 TRPV1 (0.66) KDM4EPOLB
SCHEMBL3093023 0.73 JAK2 (0.52) ALDH1A1KDM4EMAPTTDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US claimed